Abstract
Histone methyltransferase SMYD3 is a kind of protease relating to different kinds of tumors, which makes it a promising target for anticancer drugs. In order to find new small molecule inhibitors of SMYD3 for oncotherapy, a pharmacophore was created based on the crystal structure of SMYD3 with sinefungin (SFG) from Protein Data Bank (PDB ID: 3PDN) by using the software of Ligand Scout 3.1. The virtual screening of ZINC database was conducted with the pharmacophore using MOE software. Two hundred and four hits which meet at least five pharmacophore characteristics were obtained and four structural characteristics were summarized from these hits, which have laid a data foundation for the discovery of novel SMYD3 inhibitors.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Foreman KW, Brown M, Park F, Emtage S, Harriss J, Chhaya D, Zhu L, Crew A, Arnold L, Shaaban S, Tucker P (2011) Structural and functional profiling of the human histone methyltransferase SMYD3. PLoS One 6(7):e22290
Luo XG, Pan H, Liu ZP, Guo S (2009) Research progress of SMYD3 in the process of carcinogenesis. Chem Life 2:247–249
Chen LB, Xu JY, Yang Z, Wang GB (2007) Silencing SMYD3 in hepatoma demethylates RIZI promoter induces apoptosis and inhibits cell proliferation and migration. World J Gastroenterol 13(43):5718
Wang JJ, Zhang LM, Dai YP, Guo Y (2010) Effect and possible mechanism of microRNA silencing SMYD3 on invasiveness of breast cancer cell in vitro. Chin J Cancer Prev Treat 19:1532–1536
Chen J (2012) A preliminary study of histone methyltransferase SMYD3 in the role of prostate cancer cells PC3[D]. Shandong University, Shandong
LigandScout, version 1.0; Inte:Ligand GmbH, Clemesn-Maria-Hofbaurer-G. 6, 2344, Maria Enzersdorf, Austria. http://www.inteligand.com
Molecular Operating Environment (MOE) 2013.08 (2013) Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A2R7
Irwin JJ, Shoichet BK (2005) ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177–182
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 21272171).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Liu, S., Sun, Z., Zhong, Y., Cui, Q., Luo, X., Dai, Y. (2015). Pharmacophore-Based Virtual Screening and Result Analysis of Histone Methyltransferase SMYD3 Inhibitors. In: Zhang, TC., Nakajima, M. (eds) Advances in Applied Biotechnology. Lecture Notes in Electrical Engineering, vol 332. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45657-6_42
Download citation
DOI: https://doi.org/10.1007/978-3-662-45657-6_42
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45656-9
Online ISBN: 978-3-662-45657-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)